Piperacillin/ tazobactam can be used to treat the general or local bacterial infection caused by determined or susceptible bacteria: lower respiratory tract infection, urinary tract infection (mixed infection or a single bacterial infection), intraperitoneal infection, skin and soft tissue infection, bacterial sepsis, gynecological infections, etc.

It is indicated for following infections caused by sensitive bacteria: lower respiratory tract infection, urinary tract infection, septicemia, skin and soft tissue infection, bone and joint infection, and also for the prevention of operation infection.

The product can be used to treat severe infections caused by unknown pathogens or known sensitive bacteria as follows: lower respiratory infection (bronchial pneumonia and lobar pneumonia), complicating (pyelonephritis) and urinary tract infection, skin and soft tissue infection (phlegmon, skin abscess and wound infection), infection, bacteremia/septicemia occurred to those suffering neutropenia.

It is indicated for lower respiratory tract infection, urinary tract infections, and abdominal cavity infection, pelvic infection, septicemia, skin soft tissue infection, bone and joint infection caused by sensitive bacteria, and the meningitis and simple gonorrhea caused by streptococcus pneumoniae or haemophilus influenza.

It is indicated for moderate and severe infections inflicted on adult, children aged between 2 months and 16 years caused by sensitive bacteria, including lower respiratory infection (pneumonia and bronchitis), simple lower urinary tract infection and complexity of urinary tract infection (including pyelonephritis), non complex skin and skin soft-tissue infection, complexity intra-abdominal infections (including peritonitis and biliary tract infection), gynecological infections and septicemia, and the neutropenia associated with fever. It is also can be used to cure the cerebrospinal meningitis caused by bacteria for children.

It is indicated for such infections caused by sensitive gram-negative bacillus as the sepsis, lower respiratory tract infection, celiac and biliary tract infection, complexity, urinary tract infection and serious skin soft- tissue infection. In addition, it is particularly effective for such infections caused by multiple drug-resistant gram-negative bacilli as the infections inflicted on immunocompromised patients and nosocomial infection, as well as for central nervous system infections caused by gram-negative bacillus or pseudomonas aeruginosa.

It is indicated for such respiratory tract infections, genitourinary tract infections and skin and soft-tissue infections caused by sensitive bacteria as the acute pharyngitis, tonsillitis, otitis media, bronchitis and pneumonia.

It is indicated for such infections caused by sensitive bacteria as the otitis media, bronchitis, pneumonia and respiratory tract infection, urinary tract infection, skin soft tissue infection, bone and joint infection, septicemia, infective endocarditis, hepatic system infection and eye, ear, nose, and throat infections. In addition, the product can serve as the preoperative preventive drug.